Cannabis stocks rally on expectations of Trump move to ease curbs

Canopy Growth

18/12/2025 11:37

** U.S. listed shares of cannabis companies rise ahead of a potential announcement from U.S. President Donald Trump that he will sign an executive order on easing restrictions on the Schedule I narcotic and deem it a less dangerous drug on Thursday

** Shares of Cronos Group  CRON.TO, CRON.O and Aurora Cannabis ACB.TO, ACB.O, rise 4.3% and 4.5% premarket

** Tilray Brands TLRY.TO, TLRY.O  up 2.8%, and Canopy Growth WEED.TO, CGC.O jump 10.4% premarket

** Stocks have soared since reports last week emerged of Trump's plan to ease the curbs

** Under current federal law, marijuana remains a Schedule I controlled substance, which are substances with no currently accepted medical use and a high potential for abuse, alongside LSD and heroin, despite state-level medical legalization in places like California

** A potential decision could dismantle a long-standing drug policy that could ease criminal penalties, reduce tax burdens and improve access to capital for the pot industry

 (Reporting by Padmanabhan Ananthan)

 ((Padmanabhan.Ananthan@thomsonreuters.com))